SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001178913-18-000513
Filing Date
2018-02-13
Accepted
2018-02-13 12:40:50
Documents
1
Group Members
MOSHE ARKINSPHERA GLOBAL HEALTHCARE GP LTD.SPHERA GLOBAL HEALTHCARE MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zk1821197.htm SC 13G/A 115412
  Complete submission text file 0001178913-18-000513.txt   117081
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87931 | Film No.: 18601352
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 21 HA'ARBA'AH STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'AH STREET TEL AVIV L3 64739 972-3-6845535
SPHERA FUNDS MANAGEMENT LTD. (Filed by) CIK: 0001496201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13G/A